Our technology follows the discovery of synthetic machines that was awarded the 2016 Chemistry Nobel Prize to J-P Sauvage, Sir J. F Stoddart and B. L. Feringa.more information
Rotor-propelled MNMs drill and tunnel through the membranes of individual target cancer cells using their molecular-scale actuationmore information
The mechanical drilling of our Molecular NanoMachines (MNMs) can be further utilized for disruption of highly resistant bacterial cells.more information
Nanorobotics is exploring out-licensing of its core technology for other non-medical applications.more information
Previously a CEO of a start up company from idea to application and from concept to a successful publicly traded company. Extensive management and financial experience. Financially lead a variety of international and public companies. Led private equity raising for public companies. Strong Involvement in M&A transactions.
Professor of Chemistry, Materials Science and NanoEngineering Department of Chemistry, Rice University Ranked one of the Top 50 most influential scientists in the world. Over 700 research publications and over 130 patent families. Co-Founder of several companies among them Dotz, Weebit, Universal Matter.
PhD in Chemistry/Biophysics. Conducted research on Molecular NanoMachines at University of California, Berkeley. Over 14 years of Research and Development in Medtech companies, most recently CTO of Breast Cancer company with strong experience in bringing technologies from in vivo to human FDA/CE/CFDA studies.